FDA approves BioMarin drug to treat dwarfism in children

The US agency has granted approval to Voxzogo, an injectable drug designed to aid growth in children with achondroplasia, the most common form of dwarfism.

Related Keywords

United States ,Lynda Polgreen ,Jean Jacques Bienaim ,Theresa Keho ,David Geffen School Of Medicine ,Drug Administration ,Lundquist Institute At ,General Endocrinology ,Drug Evaluation ,Lundquist Institute ,David Geffen School ,Markets Amp Regulations ,Atient Centricity ,Regulations ,Delivery Formulations ,Delivery Technologies ,Drug Delivery ,Formulation ,Regulatory Affairs ,Fda ,Genetic Information ,Drug ,Children ,